The effect of seed orientation deviations on the quality of 125I prostate implants

被引:24
|
作者
Corbett, JF [1 ]
Jezioranski, JJ
Crook, J
Tran, T
Yeung, IWT
机构
[1] Princess Margaret Hosp, Dept Radiat Phys, Toronto, ON M4X 1K9, Canada
[2] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M4X 1K9, Canada
[3] Univ Toronto, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
来源
PHYSICS IN MEDICINE AND BIOLOGY | 2001年 / 46卷 / 11期
关键词
D O I
10.1088/0031-9155/46/11/303
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We quantified the effect of seed orientation deviations on five prostate seed implant cases at our institution. While keeping their positions fixed, the iodine-125 seeds were assigned orientations sampled from a realistic probability distribution derived from the post-implant radiographs of ten patients. Dose distributions were calculated with both a model that explicitly includes anisotropy (TG43 anisotropy function) and a point source model (TG43 anisotropy factor). Orientation deviations had only a small influence on prostate dose-volume histograms: the 95% confidence intervals on the volumes receiving 100%, 150% and 200% dose were at most +/-0.8%, +/-1.1% and +/-0.6% of the prostate volume, respectively. The dose-volume histograms of anisotropic seed distributions were marginally better than those with isotropic point-source seeds. Anisotropy caused a displacement of cold spots (regions receiving <100% of the prescribed dose) in <1% of the prostate volume. Our results indicate no net benefit to prostate dosimetry in using more isotropic seeds. Furthermore, we propose a new 'weighted anisotropy function' to better account for the effects of anisotropy when seed orientation is unknown. Conceptually, the TG43 anisotropy factor described in AAPM TG43 averages the effect of anisotropy over all solid angles, with the implicit assumption that all seed orientations are equally probable. In prostate implants, however, seeds are preferentially oriented parallel to the needle axis. The proposed weighted anisotropy function incorporates this non-uniform probability.
引用
收藏
页码:2785 / 2800
页数:16
相关论文
共 50 条
  • [31] 125I Seed-Loaded Stents and 125I Seed Strips for the Treatment of Unresectable Malignant Obstructive Jaundice
    Wang, Wenhui
    Li, Shuangxi
    Li, Baohua
    [J]. NANOSCIENCE AND NANOTECHNOLOGY LETTERS, 2020, 12 (03) : 418 - 425
  • [32] Preplan Dosimetry as a Predictor of Clinical Outcome for 125I Permanent Prostate Implants (PPI)
    Alexander, J.
    Weinberg, V.
    Nash, M.
    Pickett, B.
    Gottschalk, A.
    Hsu, I.
    Shinohara, K.
    Roach, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S185 - S185
  • [33] Comparison of methods for calculating rectal dose after 125I prostate brachytherapy implants
    Hilts, M
    Spadinger, I
    Keyes, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (03): : 775 - 785
  • [34] Dosimetric consequences of increased seed strength for I-125 prostate implants
    Sloboda, RS
    Pedersen, JE
    Hanson, J
    Halperin, RM
    [J]. RADIOTHERAPY AND ONCOLOGY, 2003, 68 (03) : 295 - 297
  • [35] Dosimetric consequences of increased seed strength for I-125 prostate implants
    Lee, WR
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 70 (02) : 209 - 210
  • [36] The role of prophylactic tamsulosin ± dexamethasone in patients undergoing prostate 125I seed implants for prostate carcinoma.: A randomized double-blind study
    Carlson, T
    Ciezki, J
    Elshaikh, M
    Khuntia, D
    Reddy, C
    Mahadevan, A
    Angermeier, K
    Ulchaker, J
    Klein, E
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S269 - S270
  • [37] The role of prophylactic tamsulosin (Flomax®) ± dexamethasone in patients undergoing prostate 125I seed implants for prostate carcinoma.: A randomized double blind study
    Carlson, T
    Ciezki, J
    Khuntia, D
    Elshaikh, M
    Mahadevan, A
    Reddy, C
    Ulchaker, J
    Angermeier, K
    Klein, E
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S120 - S120
  • [38] Effect of the geometry on the dosimetric parameters of the 125I brachytherapy 6711 seed
    Chaves, A.
    Lopes, M. C.
    Peralta, L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S418 - S419
  • [39] Seed Cloud Volume as Surrogate for Prostate Volume for Dosimetry of 125I Permanent Brachytherapy
    Ravindran, P.
    Sloboda, R.
    [J]. MEDICAL PHYSICS, 2010, 37 (06) : 3204 - +
  • [40] Is there a preferred strength for regularly spaced 125I seeds in inverse-planned prostate implants?
    Sloboda, RS
    Pedersen, JE
    Halperin, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (01): : 234 - 244